112 related articles for article (PubMed ID: 4006474)
41. Ranitidine clearance during hemodialysis with high-flux membrane: comparison of polysulfone and cellulose acetate hemodialyzers.
Tsuruoka S; Sugimoto KI; Hayasaka T; Saito T; Fujimura A
Eur J Clin Pharmacol; 2000 Nov; 56(8):581-3. PubMed ID: 11151748
[TBL] [Abstract][Full Text] [Related]
42. Patient survival and renal recovery in acute renal failure: randomized comparison of cellulose acetate and polysulfone membrane dialyzers.
Albright RC; Smelser JM; McCarthy JT; Homburger HA; Bergstralh EJ; Larson TS
Mayo Clin Proc; 2000 Nov; 75(11):1141-7. PubMed ID: 11075743
[TBL] [Abstract][Full Text] [Related]
43. Dialysis membranes and PTH changes during hemodialysis in patients with secondary hyperparathyroidism.
De Francisco AL; Amado JA; Prieto M; Alcalde G; Sanz de Castro S; Ruiz JC; Morales P; Arias M
Nephron; 1994; 66(4):442-6. PubMed ID: 8015649
[TBL] [Abstract][Full Text] [Related]
44. Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function.
Matzkies FK; Reinecke H; Tombach B; Kosch M; Hegger K; Milius M; Hohage H; Kisters K; Kerber S; Schaefer RM
Am J Nephrol; 2000; 20(4):300-4. PubMed ID: 10970983
[TBL] [Abstract][Full Text] [Related]
45. Effects of high-flux hemodialysis on oxidant stress.
Ward RA; Ouseph R; McLeish KR
Kidney Int; 2003 Jan; 63(1):353-9. PubMed ID: 12472803
[TBL] [Abstract][Full Text] [Related]
46. The development of a polysulfone membrane. A new perspective in dialysis?
Streicher E; Schneider H
Contrib Nephrol; 1985; 46():1-13. PubMed ID: 4006470
[No Abstract] [Full Text] [Related]
47. [Hemodynamic studies in chronic terminal renal insufficiency--Effects of hemodialysis (Hd), hemofiltration (Hf) and ultrafiltration (Uf) procedures (author's transl)].
Jahn H; Schohn D; Schmitt R
Nephrologie; 1981; 2(2):53-62. PubMed ID: 7290301
[TBL] [Abstract][Full Text] [Related]
48. Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
Klemm A; Sperschneider H; Winnefeld K; Günther K; Stein G
Clin Nephrol; 1997 Feb; 47(2):133-4. PubMed ID: 9049466
[No Abstract] [Full Text] [Related]
49. Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes.
Cianciolo G; Stefoni S; Donati G; De Pascalis A; Iannelli S; Manna C; Colì L; Bertuzzi V; La Manna G; Raimondi C; Boni P; Stefoni V
Nephrol Dial Transplant; 2001 Jun; 16(6):1222-9. PubMed ID: 11390724
[TBL] [Abstract][Full Text] [Related]
50. Removal of hormones by hemofiltration and hemodialysis with a highly permeable polysulfone membrane.
Wizemann V; Velcovsky HG; Bleyl H; Brüning S; Schütterle G
Contrib Nephrol; 1985; 46():61-8. PubMed ID: 2408819
[No Abstract] [Full Text] [Related]
51. [Level of total plasma carnitine in patients with chronic renal failure in the course of diabetes and other etiologies treated with hemodialysis].
Gumprecht J; Snit M; Zukowska-Szczechowska E; Grzeszczak W; Moczulski D; Jendryczko A
Pol Arch Med Wewn; 1995 Nov; 94(5):403-9. PubMed ID: 8833937
[TBL] [Abstract][Full Text] [Related]
52. Apoptotic markers on lymphocytes and monocytes are unchanged during single hemodialysis sessions using either regenerated cellulose or polysulfone membranes.
Wu CC; Liao TN; Lu KC; Chen JS; Chu P; Lin SH; Chuang CH; Lin YF
Clin Nephrol; 2005 Sep; 64(3):198-204. PubMed ID: 16175944
[TBL] [Abstract][Full Text] [Related]
53. Long-term experience with high-flux polysulfone in hemodialysis.
Civati G; Teatini U; Guastoni C; Perego A; Perrino ML; Ballerini L; Minetti L
Clin Nephrol; 1994 Jul; 42 Suppl 1():S26-30. PubMed ID: 7923979
[No Abstract] [Full Text] [Related]
54. Acute intradialytic well-being: results of a clinical trial comparing polysulfone with cuprophan. Bergamo Collaborative Dialysis Study Group.
Kidney Int; 1991 Oct; 40(4):714-9. PubMed ID: 1745022
[TBL] [Abstract][Full Text] [Related]
55. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
Mrowka C; Heintz B; Sieberth HG
Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
[TBL] [Abstract][Full Text] [Related]
56. Factors affecting blood pressure in hemodialysis.
Wehle B
Scand J Urol Nephrol Suppl; 1982; 69():1-66. PubMed ID: 6755691
[No Abstract] [Full Text] [Related]
57. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
[TBL] [Abstract][Full Text] [Related]
58. [Hemodynamics during consecutive ultrafiltration with hemodialysis and hemodiafiltration].
Kulakov GP; Avtandilov AG; Konovalov GA
Sov Med; 1983; (9):29-33. PubMed ID: 6648677
[No Abstract] [Full Text] [Related]
59. [Hemodynamics during hemodialysis, hemofiltration and hemodiafiltration using bicarbonate vs acetate buffers].
Liomin E; Schneider H; Streicher E
Klin Wochenschr; 1984 Oct; 62(19):911-9. PubMed ID: 6503213
[TBL] [Abstract][Full Text] [Related]
60. Hemodynamic study of hypotension during hemodialysis.
Kinet JP; Soyeur D; Balland N; Saint-Remy M; Collignon P; Godon JP
Kidney Int; 1982 Jun; 21(6):868-76. PubMed ID: 7132055
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
